• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Latest Cannabis Hires And Board Changes, Here's What You Need To Know

    7/12/24 5:26:17 PM ET
    $CL
    $HITI
    $VRPX
    Package Goods/Cosmetics
    Consumer Discretionary
    Other Specialty Stores
    Consumer Discretionary
    Get the next $CL alert in real time by email

    As Benzinga Cannabis Capital Conference returns to Chicago this Oct. 8-9 for its 19th edition, gathering top CEOs, investors investors and leaders in the cannabis industry, let's scroll through the latest leadership changes in the space. Get your tickets now before prices surge by following this link.

    Cannabis ancillary company EnWave Corporation (TSXV:ENW) (FSE: E4U) announced on Thursday that it had tapped Danna Dunnage as its new vice president of global sales and business development.

    Dunnage joins EnWave bringing vast executive experience, having spent over 25 years in sales and strategy roles in the food service, distribution, hospitality and SAAS industries.

    The Vancouver-based company hired Dunnage as part of its enhanced sales strategy, attracting top-level sales talent and growing its presence internationally.

    The company said that it intends to hire two additional sales managers in the near term who are domiciled in key global markets – Europe and South Asian region – who will report to Dunnage.

    Read Also: Latest Key Hires & Board Changes In Cannabis Industry: Canopy Growth, Acreage And More

    Cannabis Board Updates

    Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX), announced recently the changes to its board of directors with the appointments of Judy Su, Gary Herman, Jatinder Dhaliwal and Katharyn Field. Resignations from Virpax's board were tendered effective upon consummation of the financing by Jeffrey Gudin, Thanigavelan Jambulingam, Michael Dubin, Jerrold Sendrow and Barbara Ruskin.

    The shareholders at Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) elected at its annual general and special meeting held on July 10, 2024, the following nominees as directors, including:

    • Charles Bachtell
    • Tarik Brooks
    • Gerald F. Corcoran
    • Marc Lustig
    • Thomas J. Manning
    • Randy D. Podolsky
    • Michele Roberts
    • Robert M. Sampson.

    Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced earlier this week that all of management's nominees listed in the company's management information circular dated May 31, 2024, were elected as directors of the company at its annual general meeting of shareholders held also on July 10, 2024.

    The following nominees are elected as directors:

    • Aras Azadian
    • Giancarlo Davila Char
    • Paul Fornazzari
    • Eileen McCormack
    • John McVicar

    High Tide Inc. (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA) announced on Wednesday that its shareholders have elected the following nominees listed in the company’s management information circular dated May 27, 2024, as directors of the company;

    • Harkirat Raj Grover
    • Nitin Kaushal
    • Arthur Kwan
    • Christian Sinclair
    • Andrea Elliott

    Read Next

    • Executive Changes In Cannabis Industry You Should Know About, New Appointments & More
    Get the next $CL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CL
    $HITI
    $VRPX

    CompanyDatePrice TargetRatingAnalyst
    Colgate-Palmolive Company
    $CL
    1/13/2026$86.00Underweight → Equal Weight
    Wells Fargo
    Colgate-Palmolive Company
    $CL
    1/7/2026$88.00Neutral → Overweight
    Piper Sandler
    Colgate-Palmolive Company
    $CL
    12/11/2025Buy → Hold
    Argus
    Colgate-Palmolive Company
    $CL
    12/9/2025$88.00Sector Perform → Outperform
    RBC Capital Mkts
    Colgate-Palmolive Company
    $CL
    10/3/2025$84.00Neutral
    Piper Sandler
    Colgate-Palmolive Company
    $CL
    10/28/2024$105.00 → $101.00Buy → Hold
    Stifel
    Colgate-Palmolive Company
    $CL
    9/24/2024$121.00Overweight
    Piper Sandler
    Colgate-Palmolive Company
    $CL
    9/16/2024$100.00Equal Weight → Underweight
    Wells Fargo
    More analyst ratings

    $CL
    $HITI
    $VRPX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Growth Officer Hazlin John exercised 20,989 shares at a strike of $76.41 and sold $1,978,211 worth of shares (20,989 units at $94.25) (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    2/12/26 4:08:05 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    EVP and Controller Malcolm Gregory exercised 12,747 shares at a strike of $76.41 and sold $1,209,822 worth of shares (12,747 units at $94.91) (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    2/10/26 4:21:26 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Chief Human Resources Officer Massey Sally exercised 15,851 shares at a strike of $76.41 and sold $1,506,287 worth of shares (15,851 units at $95.03) (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    2/9/26 4:16:04 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    $HITI
    $VRPX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    High Tide Opens New Canna Cabana in Scarborough, Ontario

    CALGARY, AB, Feb. 9, 2026 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that its Canna Cabana retail cannabis store located at 3148 Kingston Road in Scarborough, Ontario, began selling recreational cannabis products and consumption accessories for adult use today on February 9, 2026. This opening brings High Tide's total store count to 219 Canna Cabana locations across Canada and 95 in the province of Ontario.

    2/9/26 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Colgate-Palmolive Webcasts Presentation at The Consumer Analyst Group of New York Conference

    Colgate-Palmolive (NYSE:CL) Chairman, President and CEO, Noel Wallace, and SVP, Global Growth and Innovation, Hill's Pet Nutrition, Caroline Chulick, will present on Friday, February 20, 2026 at 8:00 am ET at the Consumer Analyst Group of New York Conference. Investors may access a live webcast of this presentation and the presentation slides on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the ‘Investor Center' page of Colgate's website. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, t

    2/6/26 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results

    Colgate-Palmolive Company (NYSE:CL): Full Year Net sales and Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume GAAP EPS declined 25% to $2.63, driven by goodwill and intangible assets impairment charges related to the skin health business Base Business EPS* increased 3% to $3.69 Net cash provided by operations was a record $4,198 for the full year Returned $2.9 billion in cash to shareholders through dividends and share repurchases Full Year Total Company Results (GAAP) ($ in millions except per share amounts) 2025 2024 Change Net Sales $20,382 $20,101 +1.4% EP

    1/30/26 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    $HITI
    $VRPX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Colgate-Palmolive upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Colgate-Palmolive from Underweight to Equal Weight and set a new price target of $86.00

    1/13/26 8:40:58 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Colgate-Palmolive from Neutral to Overweight and set a new price target of $88.00

    1/7/26 8:42:57 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive downgraded by Argus

    Argus downgraded Colgate-Palmolive from Buy to Hold

    12/11/25 8:17:14 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    $HITI
    $VRPX
    SEC Filings

    View All

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    2/9/26 8:26:09 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Amendment: SEC Form 40-F/A filed by High Tide Inc.

    40-F/A - High Tide Inc. (0001847409) (Filer)

    2/3/26 12:41:27 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    1/30/26 9:18:03 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $CL
    $HITI
    $VRPX
    Leadership Updates

    Live Leadership Updates

    View All

    High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH

    Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase

    8/14/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Provides Corporate Updates

    CALGARY, AB, Aug. 12, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to provide several corporate updates. Germany Update High Tide is pleased to share that it continues to make solid progress on the previously disclosed proposed transaction with a leading German medical cannabis importer and wholesaler. This contemplated transaction is already fully funded following the junior secured loan the Com

    8/12/25 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Announces Voting Results of Annual General and Special Meeting of Shareholders

    CALGARY, AB, May 30, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today the voting results from its annual general and special meeting of shareholders of the Company held on May 29, 2025 (the "Meeting"). Each nominee listed in the Company's management information circular dated April 17, 2025, was elected as a director of the Company. Each of the following five nominees proposed by management was

    5/30/25 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $CL
    $HITI
    $VRPX
    Financials

    Live finance-specific insights

    View All

    Colgate-Palmolive Company Announces 4th Quarter and Full Year 2025 Results

    Colgate-Palmolive Company (NYSE:CL): Full Year Net sales and Organic sales* increased 1.4%, including a 0.7% negative impact from lower private label pet volume GAAP EPS declined 25% to $2.63, driven by goodwill and intangible assets impairment charges related to the skin health business Base Business EPS* increased 3% to $3.69 Net cash provided by operations was a record $4,198 for the full year Returned $2.9 billion in cash to shareholders through dividends and share repurchases Full Year Total Company Results (GAAP) ($ in millions except per share amounts) 2025 2024 Change Net Sales $20,382 $20,101 +1.4% EP

    1/30/26 6:55:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    High Tide Reports Fourth Quarter and 2025 Year End Financial Results Featuring Record Revenue and Adjusted EBITDA

    The Company remains FCF positive for the fiscal year, while delivering strong same-store sales growth and cementing its presence within the German medical cannabis market Canadian Cabana Club Members Now Exceed 2.5 Million, Up 45% Year Over Year, Marking the Fastest Pace in Four Quarters ELITE Members in Canada Have Surpassed 151,000, Once Again Growing at the Fastest Rate Since Inception In Fiscal 2025, Same-Store Sales Were Up 4.1%. For the Fourth Fiscal Quarter, Same-Store Sales Rose 5.5% Year Over YearThe Company Opened 27 New Canna Cabana Locations Organically in Calendar 2025, Achieving the Higher End of Its Communicated Goal, and Remains the Largest Cannabis Retailer in Canada with 21

    1/29/26 4:01:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Colgate-Palmolive Webcasts 2025 Fourth Quarter & Full Year Earnings Conference Call January 30, 2026 – 8:30 a.m. ET

    Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website.

    1/16/26 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    $HITI
    $VRPX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Virpax Pharmaceuticals Inc.

    SC 13G - Virpax Pharmaceuticals, Inc. (0001708331) (Subject)

    5/23/24 4:06:37 PM ET
    $VRPX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Colgate-Palmolive Company (Amendment)

    SC 13G/A - COLGATE PALMOLIVE CO (0000021665) (Subject)

    2/13/24 5:02:36 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form SC 13G/A filed by Virpax Pharmaceuticals Inc. (Amendment)

    SC 13G/A - Virpax Pharmaceuticals, Inc. (0001708331) (Subject)

    1/2/24 10:11:28 AM ET
    $VRPX
    Biotechnology: Pharmaceutical Preparations
    Health Care